TABLE 3.

Distribution of combined GM 1,17 5,13 and KM 3 phenotypes in relation to persistence and clearance of HCV infection

PhenotypesNo. (%) of subjectsa with indicated HCV infection outcomeOR95% confidence intervalP
PersistentCleared
GM 1,17 5,13 (+)/KM 3 (+)28 (14.4)11 (11.5)0.900.40-2.030.80
GM 1,17 5,13 (+)/KM 3 (−)16 (8.3)18 (18.8)2.751.21-6.230.01
GM 1,17 5,13 (−)/KM 3 (+)75 (38.7)35 (36.5)1.020.57-1.830.94
GM 1,17 5,13 (−)/KM 3 (−)75 (38.7)32 (33.3)1.00
  • a Persistence, n = 194; clearance, n = 96; missing GM and/or KM typing, n = 8.